Dr. Daniel J. Drucker
Medicine at the University
Biography & Research Background
Daniel J. Drucker, OC, MD, FRSC, is a Senior Investigator at the Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, and Professor of Medicine at the University of Toronto. Dr. Drucker is one of the world's foremost authorities on incretin biology and the GIP and GLP-1 hormone systems that underlie dual incretin agonists such as tirzepatide, with over 800 publications and numerous awards including the Canada Gairdner International Award and the Banting Medal for Scientific Achievement. Daniel J. Drucker is being referenced as one of the leading scientists in the field of incretin (GIP/GLP-1) research relevant to Tirzepatide. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of this product for any reason. There is no affiliation or relationship, implied or otherwise, between Pure US Peptide and this doctor.
External Profiles
Authored Research Profiles (1)
Dr. Daniel J. Drucker is referenced as a leading researcher in the following peptide research profiles on Pure U.S. Peptides:
Dr. Daniel J. Drucker is being referenced as one of the leading scientists involved in the research and development of the peptides listed above. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of any product for any reason. There is no affiliation or relationship, implied or otherwise, between Pure U.S. Peptides and this researcher. The purpose of citing the researcher is to acknowledge, recognize, and credit the exhaustive research and development efforts conducted by the scientists studying these peptides.